Fidelity Investments’s Oruka Therapeutics ORKA Stock Holding History

Fidelity Investments’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$365M	Buy	7,431,403 +170,019	+2%	+$5.91M	0.02%	631
2025 Q4	$220M	Buy	7,261,384 +3,763	+0.1%	+$105K	0.01%	831
2025 Q3	$140M	Buy	7,257,621 +1,641,150	+29%	+$24.3M	0.01%	1022
2025 Q2	$63M	Buy	5,616,471 +54,663	+1%	+$570K	﹤0.01%	1301
2025 Q1	$57.1M	Buy	5,561,808 +49,508	+0.9%	+$617K	﹤0.01%	1306
2024 Q4	$107M	Buy	5,512,300 +830,000	+18%	+$20.2M	0.01%	1094
2024 Q3	$115M	Buy	+4,682,300	New	+$163M	0.01%	1046
2024 Q2	–	Sell	-17	Closed	-$358	–	5679
2024 Q1	$358	Buy	+17	New	+$338	﹤0.01%	4873
2019 Q4	–	Sell	-2	Closed	–	–	4333
2019 Q3	$0	Buy	+2	New	+$147	﹤0.01%	4293

Other funds holding ORKA

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments's ORKA Position: Q1 2026 in Review

Fidelity Investments increased its Oruka Therapeutics (ORKA) stake by 2.3% in Q1 2026, buying an estimated $5.91M and bringing the position to 7,431,403 shares worth $365M. The position accounts for 0.02% of the portfolio, ranked #631.

Fidelity Investments first reported a position in ORKA in Q3 2019 and has held it in 9 quarters since. 184 funds tracked by Wall St. Rank hold ORKA as of Q1 2026.

Fidelity Investments held 7,431,403 shares of Oruka Therapeutics worth $365M as of Q1 2026.
Fidelity Investments bought 170,019 Oruka Therapeutics shares in Q1 2026, an estimated $5.91M.
Oruka Therapeutics made up 0.02% of Fidelity Investments's portfolio in Q1 2026, its #631 holding.
Fidelity Investments first reported a position in Oruka Therapeutics in Q3 2019 and has held it in 9 quarters since.
184 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.